Nationwide Estimates of 30-Day Readmission in Patients With Ischemic Stroke

Stroke. 2017 May;48(5):1386-1388. doi: 10.1161/STROKEAHA.116.016085. Epub 2017 Apr 7.

Abstract

Background and purpose: Readmission within 30 days of hospital discharge for ischemic stroke is an important quality of care metric. We aimed to provide nationwide estimates of 30-day readmission in the United States, describe important reasons for readmission, and sought to explore factors associated with 30-day readmission, particularly the association with recanalization therapy.

Methods: We conducted a weighted analysis of the 2013 Nationwide Readmission Database to represent all US hospitalizations. Adult patients with acute ischemic stroke including those who received intravenous tissue-type plasminogen activator and intra-arterial therapy were identified using International Classification of Diseases-Ninth Revision codes. Readmissions were defined as any readmission during the 30-day post-index hospitalization discharge period for the eligible patient population. Proportions and 95% confidence intervals for overall 30-day readmissions and for unplanned and potentially preventable readmissions are reported. Survey design logistic regression models were fit for determining crude and adjusted odds ratios and 95% confidence interval for association between recanalization therapy and 30-day readmission.

Results: Of the 319 317 patients with acute ischemic stroke, 12.1% (95% confidence interval, 11.9-12.3) were readmitted. Of these, 89.6% were unplanned and 12.9% were potentially preventable. More than 20% of all readmissions were attributable to acute cerebrovascular disease. Readmitted patients were older and had a higher comorbidity burden. After controlling for age, sex, insurance status, and comorbidities, patients who underwent recanalization therapy had significantly lower odds of 30-day readmission (odds ratio, 0.82; 95% confidence interval, 0.77-0.89).

Conclusions: Up to 12% of patients with ischemic stroke get readmitted within 30 days post-discharge period, and recanalization therapy is associated with 11% to 23% lower odds of 30-day readmission.

Keywords: brain ischemia; cerebrovascular disorders; patient discharge; patient readmission; stroke.

MeSH terms

  • Brain Ischemia / drug therapy
  • Brain Ischemia / therapy*
  • Fibrinolytic Agents / therapeutic use*
  • Humans
  • Patient Readmission / statistics & numerical data*
  • Stroke / drug therapy
  • Stroke / therapy*
  • Time Factors
  • Tissue Plasminogen Activator / therapeutic use*
  • United States
  • Vascular Surgical Procedures / statistics & numerical data*

Substances

  • Fibrinolytic Agents
  • Tissue Plasminogen Activator